News and Announcements
MedAdvisor to Launch New Pharmacy Software to Improve Services
- Published February 06, 2017 2:21PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
- First phase of this new innovative technology integration of MedAdvisor and Healthnotes now complete, with the first roll out of the new pharmacy technology software underway.
- The Company has decided to expand in order to assist pharmacies and patients with more “readily and reliable” accessible services.
- MedAdvisor has planned to settle the OzDocsOnline transaction on the 17th of February 2017.
MedAdvisor is pleased to announce that they have completed their first stage with Healthnotes for the collaboration of the technical integration. This new pharmacy application will be installed into MedAdvisor pharmacies, the rollout is expected to reach existing customers by the 10th of February.
The new technology will be officially launched at the Australian Pharmacy Professional Conference held in March 2017. Further enhancements to the technology will continue throughout FY17 to enhance and establish the software.
Prior to the agreement with Healthnotes, MedAdvisor utilised Guildlink’s pharmacy product; to enable and host the MedAdvisor Application. With their services the Guildlink’s Agreement will come to an end on February 10, 2017 and MedAdvisor will no longer have dependency on the GuildCare Platform for its service.
MedAdvisor has estimated their acquisition with OzDocsOnline to come through on the 17th of February, 2017, which will provide new technologies and expanding their patient network. MedAdvisor is also pleased to also announce the strong network that will come from their GPs that will drive user acquisition of the GP Link Platform.
The CEO of MedAdvisor, Mr Robert Read, commented: “I have been exceptionally pleased with our operational and financial performance over the past year and the first milestone in our technical integration of our software with Healthnotes signifies our evolution as a business […] Overall, this new technology will enable us to assist pharmacies to provide improved healthcare for their patients”.
To view the full ASX Announcement, please click here.
Company Updates
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
Backed By Leading Investment Groups and Family Offices
